DANESE, SILVIO
 Distribuzione geografica
Continente #
AS - Asia 12.377
NA - Nord America 5.760
SA - Sud America 5.325
EU - Europa 5.211
AF - Africa 356
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 29.065
Nazione #
US - Stati Uniti d'America 5.393
SG - Singapore 4.658
BR - Brasile 4.464
CN - Cina 2.969
HK - Hong Kong 2.080
SE - Svezia 1.485
VN - Vietnam 1.426
IT - Italia 754
RU - Federazione Russa 712
DE - Germania 523
FI - Finlandia 414
AR - Argentina 340
RO - Romania 287
GB - Regno Unito 240
ID - Indonesia 183
IN - India 180
BD - Bangladesh 174
AT - Austria 173
EC - Ecuador 158
CA - Canada 144
JP - Giappone 134
MX - Messico 133
ZA - Sudafrica 130
NL - Olanda 111
CO - Colombia 97
IQ - Iraq 90
PY - Paraguay 86
PL - Polonia 80
TR - Turchia 77
CZ - Repubblica Ceca 76
ES - Italia 69
FR - Francia 65
PK - Pakistan 60
MA - Marocco 58
VE - Venezuela 56
UZ - Uzbekistan 53
EG - Egitto 49
UA - Ucraina 49
IE - Irlanda 45
UY - Uruguay 41
PE - Perù 38
CL - Cile 37
SA - Arabia Saudita 30
TN - Tunisia 27
IL - Israele 26
AE - Emirati Arabi Uniti 25
AZ - Azerbaigian 25
DZ - Algeria 23
DO - Repubblica Dominicana 20
KE - Kenya 20
AU - Australia 18
JO - Giordania 18
TW - Taiwan 18
IR - Iran 17
KZ - Kazakistan 17
LT - Lituania 17
NP - Nepal 17
AL - Albania 13
KR - Corea 13
BE - Belgio 12
BG - Bulgaria 12
HN - Honduras 12
KW - Kuwait 12
PT - Portogallo 12
RS - Serbia 12
BH - Bahrain 11
PA - Panama 11
CH - Svizzera 10
OM - Oman 10
SN - Senegal 10
TT - Trinidad e Tobago 10
ET - Etiopia 9
EU - Europa 9
MY - Malesia 8
BY - Bielorussia 7
LB - Libano 7
GT - Guatemala 6
NI - Nicaragua 6
BO - Bolivia 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
JM - Giamaica 5
KG - Kirghizistan 5
NG - Nigeria 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CD - Congo 4
GR - Grecia 4
KH - Cambogia 4
PH - Filippine 4
PS - Palestinian Territory 4
QA - Qatar 4
SI - Slovenia 4
TG - Togo 4
AO - Angola 3
DK - Danimarca 3
GY - Guiana 3
Totale 29.015
Città #
Hong Kong 2.058
Singapore 1.787
Dallas 1.028
Hefei 840
Shanghai 753
Lawrence 702
Princeton 700
Ashburn 612
Ho Chi Minh City 579
Moscow 384
Beijing 364
São Paulo 352
Helsinki 345
New York 311
Hanoi 291
Los Angeles 170
Milan 164
Nuremberg 148
Rio de Janeiro 139
Munich 109
Brasília 93
Belo Horizonte 87
Tokyo 79
Vienna 78
Olomouc 73
Campinas 72
Curitiba 71
Porto Alegre 69
Warsaw 66
Haiphong 64
Montreal 60
Johannesburg 59
London 59
Rome 59
Salvador 58
Da Nang 54
Quito 52
Guayaquil 51
Biên Hòa 50
Brooklyn 50
Boardman 49
Tashkent 49
Stockholm 48
Buenos Aires 46
Poplar 46
Chicago 45
Baghdad 41
Guangzhou 41
Guarulhos 41
Chennai 40
Denver 40
Dublin 39
Atlanta 36
Dhaka 36
Orem 36
Lappeenranta 35
Montevideo 35
Ribeirão Preto 35
Santa Clara 35
Seattle 35
Phoenix 34
Asunción 33
Mexico City 33
Hải Dương 32
Frankfurt am Main 31
Manaus 31
Santo André 31
Amsterdam 30
Goiânia 30
Borås 29
Jakarta 29
Lima 29
Recife 29
Sorocaba 29
Boston 28
Cape Town 28
Manchester 28
Turku 28
Thái Bình 27
Ankara 26
Caxias do Sul 26
Baku 25
Fortaleza 25
Hangzhou 24
Juiz de Fora 24
Tianjin 24
Uberlândia 24
Duque de Caxias 23
Falkenstein 23
Houston 23
Osasco 23
Delhi 22
Canoas 21
Mumbai 21
Toronto 21
Hortolândia 20
Bologna 19
Cuiabá 19
Joinville 19
João Pessoa 19
Totale 14.988
Nome #
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines 380
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 150
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 144
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 120
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 120
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 117
Crohn's disease 116
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 113
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 108
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 90
Inflammation and malnutrition in inflammatory bowel disease 89
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 88
New therapeutic avenues in ulcerative colitis: thinking out of the box 85
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 75
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 73
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 73
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies 71
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 70
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 70
The Endoscopic Management of Zenker’s Diverticulum: A Comprehensive Review 69
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 69
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 69
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 69
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX (R) (Cortiment (R)(MMX (R))) for active, mild-to-moderate ulcerative colitis 68
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 67
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 66
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 66
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 65
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 65
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 64
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 64
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 63
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 62
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 61
Clinical Pathologic Challenge Saxophone Penis: Challenge 61
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 61
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 61
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 60
VAC-Stent in the Treatment of Post-Esophagectomy Anastomotic Leaks: A New “Kid on the Block” Who Marries the Best of Old Techniques—A Review 60
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 60
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 60
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 59
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 59
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 59
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 58
Ustekinumab as induction and maintenance therapy for Crohn's disease 58
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 57
Dual-channel endoscope for double-traction endoscopic device-assisted full-thickness resection of rectal superficial tumor 57
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 57
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 57
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 57
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 57
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 57
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 56
A snapshot of the ongoing clinical research on COVID-19 56
Correction to: Understanding the therapeutic toolkit for inflammatory bowel disease (Nature Reviews Gastroenterology & Hepatology, (2025), 22, 6, (371-394), 10.1038/s41575-024-01035-7) 55
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 55
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 55
LeMann Index Assessment Overtime in Crohn's Disease Patients Treated With Anti TNFs: A Pilot Observational Cohort Study 55
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting 54
Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” era 54
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS 54
Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis 54
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 53
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 53
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX (R) for mild-to-moderate ulcerative colitis 53
Biological agents for ulcerative colitis : Hypes and hopes 53
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey 52
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 52
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 52
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 52
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis 51
Clinical Pathologic Challenge Saxophone Penis: Challenge 50
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 50
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 50
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 50
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 50
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 49
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 49
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 49
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 49
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities 49
Colonic diverticular disease 49
Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses 49
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 48
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1 48
LONG-TERM SAFETY OF VEDOLIZUMAB IN ULCERATIVE COLITIS AND CROHN'S DISEASE: FINAL RESULTS FROM THE GEMINI LTS STUDY 48
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 48
Publisher Correction: Crohn's disease 48
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 48
Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials 48
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis 48
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? 47
Small Bowel Cancer in Crohn’s Disease 47
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 47
Bowel ultrasound is accurate in assessing disease activity in ulcerative colitis 47
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer 47
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology 47
Angiogenesis blockade as a new therapeutic approach to experimental colitis 47
Epithelial NEMO links innate immunity to chronic intestinal inflammation 47
Totale 6.626
Categoria #
all - tutte 260.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 260.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/20241.129 31 38 62 52 54 196 26 70 2 45 107 446
2024/202510.277 1.159 43 133 88 80 659 1.838 1.057 1.983 1.802 653 782
2025/202614.326 2.473 2.248 2.300 4.520 2.224 561 0 0 0 0 0 0
Totale 30.058